ArticleFrontiers in immunologyPublished
Guselkumab binding to CD64+ IL-23-producing myeloid cells enhances potency for neutralizing IL-23 signaling
22 of 36 authors shown in byline order.
Regional connection
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
- Institution
- Johnson & Johnson
- County
- Montgomery County
Publication record
- Type
- Article
- Venue
- Frontiers in immunology
- Published
- Subject terms
- Monocytes; Myeloid Cells; Humans; Psoriasis; Receptors, IgG; Antibodies, Monoclonal; Signal Transduction; Protein Binding; Interleukin-23; Interleukin-23 Subunit p19; Antibodies, Monoclonal, Humanized; IL-23
- PubMed ID
- 40145093
- PubMed Central ID
- PMC11937023
- Open access
- Yes, open
- Added to directory
- Source checked